Literature DB >> 12027253

Effects of Porphyromonas gingivalis on the central nervous system: activation of glial cells and exacerbation of experimental autoimmune encephalomyelitis.

Lior Shapira1, Sharon Ayalon, Talma Brenner.   

Abstract

BACKGROUND: Several studies have suggested that peripheral inflammation may be involved in the etiology of multiple sclerosis (MS), a demyelinating disease of the central nervous system (CNS). T-cells activated in the periphery enter the CNS, leading to demyelination and axonal loss. We hypothesized that peripheral infection by Porphyromonas gingivalis can affect pathological processes in the CNS and aggravate MS.
METHODS: Glial cells derived from rat brains were cultured and stimulated with P. gingivalis or P. gingivalis lipopolysaccharide (LPS). Secretion of nitric oxide (NO) and prostaglandin E2 (PGE2) was determined. In addition, we examined the proliferation of lymphocytes harvested from P. gingivalis-immunized mice in response to stimulation by echephalitogenic proteins. The effect of peripheral inflammation induced by P. gingivalis on the clinical course of the disease was tested in experimental autoimmune encephalomyelitis (EAE), a mouse model used for the study of MS.
RESULTS: P. gingivalis LPS and heat-killed bacteria induced secretion of the proinflammatory mediators NO and PGE2 by CNS glial cells. Lymphocytes derived from P. gingivalis-immunized mice proliferated in the presence of the echephalitogenic protein myelin basic protein. Injection of P. gingivalis into subcutaneous chambers in mice, followed by EAE induction led to aggravation of the disease.
CONCLUSIONS: The present study provides evidence that infection with a periodontal pathogen, such as P. gingivalis, may play a role in the pathogenesis of CNS inflammatory disorders such as MS.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12027253     DOI: 10.1902/jop.2002.73.5.511

Source DB:  PubMed          Journal:  J Periodontol        ISSN: 0022-3492            Impact factor:   6.993


  13 in total

Review 1.  The Gut Microbiome and Multiple Sclerosis.

Authors:  Javier Ochoa-Repáraz; Trevor O Kirby; Lloyd H Kasper
Journal:  Cold Spring Harb Perspect Med       Date:  2018-06-01       Impact factor: 6.915

Review 2.  The Second Brain: Is the Gut Microbiota a Link Between Obesity and Central Nervous System Disorders?

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Curr Obes Rep       Date:  2016-03

3.  Streptococcus pneumoniae Infection aggravates experimental autoimmune encephalomyelitis via Toll-like receptor 2.

Authors:  Isabel Herrmann; Markus Kellert; Hauke Schmidt; Alexander Mildner; Uwe K Hanisch; Wolfgang Brück; Marco Prinz; Roland Nau
Journal:  Infect Immun       Date:  2006-08       Impact factor: 3.441

4.  Deep DNA metagenomic sequencing reveals oral microbiome divergence between monozygotic twins discordant for multiple sclerosis severity.

Authors:  Anne I Boullerne; Guy R Adami; Joel L Schwartz; Demetrios Skias; Mark Maienschein-Cline; Stefan J Green; Douglas L Feinstein
Journal:  J Neuroimmunol       Date:  2020-04-07       Impact factor: 3.478

5.  Unique lipids from a common human bacterium represent a new class of Toll-like receptor 2 ligands capable of enhancing autoimmunity.

Authors:  Frank C Nichols; William J Housley; Catherine A O'Conor; Thomas Manning; Shuang Wu; Robert B Clark
Journal:  Am J Pathol       Date:  2009-10-22       Impact factor: 4.307

Review 6.  The influence of gut-derived CD39 regulatory T cells in CNS demyelinating disease.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  Transl Res       Date:  2016-07-28       Impact factor: 7.012

Review 7.  Methamphetamine effects on blood-brain barrier structure and function.

Authors:  Nicole A Northrop; Bryan K Yamamoto
Journal:  Front Neurosci       Date:  2015-03-04       Impact factor: 4.677

Review 8.  Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives.

Authors:  Fengna Chu; Mingchao Shi; Yue Lang; Donghui Shen; Tao Jin; Jie Zhu; Li Cui
Journal:  Mediators Inflamm       Date:  2018-04-02       Impact factor: 4.711

Review 9.  Role of diet in regulating the gut microbiota and multiple sclerosis.

Authors:  John Michael S Sanchez; Ana Beatriz DePaula-Silva; Jane E Libbey; Robert S Fujinami
Journal:  Clin Immunol       Date:  2020-03-07       Impact factor: 3.969

Review 10.  Gut microbiome and the risk factors in central nervous system autoimmunity.

Authors:  Javier Ochoa-Repáraz; Lloyd H Kasper
Journal:  FEBS Lett       Date:  2014-10-05       Impact factor: 4.124

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.